Immuno-Oncology 360° Community News’ Post

Check out the latest issue of the Journal of Clinical Pathways! https://lnkd.in/e9jWbhws Featured stories include:   Christi Ann Hayes, MD, et al investigate whether PROMs can reliably monitor areas that impact quality of life of HSCT recipients over time.   Rebecca Previs, MD, and colleagues discuss current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful CGP testing.   Randy Vogenberg, PhD, FASHP, examines the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.   Lee Blansett, MBA, summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.   #JournalOfClinicalPathways #ValueBasedCare #CancerCare #TransformativeEmployerTrends #DecisionMaking #HealthCareRisks #BiomarkerTesting #StemCells #HematopoieticStemCellTransplant #ComprehensiveGenomicTesting

Consider incorporating immunotherapy as a potential treatment option for soft tissue sarcoma, which has shown promising results in reducing the risk of relapse by 43% at two years. This breakthrough highlights the importance of exploring innovative treatment approaches for rare cancers like sarcoma, emphasizing the significance of ongoing research efforts and clinical trials. Consult with healthcare professionals to discuss personalized treatment plans that may include immunotherapy for improved outcomes and long-term benefits. #ImmunotherapyBreakthrough #SoftTissueSarcoma #ResearchAdvances #HealthcareInnovation #CancerTreatmentOptions BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X. Read more about this post here: https://lnkd.in/eVQC6nzG

The significance of therapeutic isotopes like 225Ac and 177Lu in advancing modern medicine cannot be overstated. Their targeted approach minimized side effects, and potential for personalized treatments have transformed the landscape of cancer therapy and beyond. With the integration of MIKROS micro dispenser, the promise of precision medicine is further realized, empowering healthcare professionals to deliver advanced medical treatments with unparalleled accuracy and efficacy. Read the article: https://bit.ly/4aQMfwl #ComecerForRadiopharma #ComecerSolutions

What is Pharmacogenomics? 🧬💊 It is a blueprint that helps doctors choose the right medicine for YOU based on your genes. Josiah Allen, PharmD breaks down the science and how Pharmacogenomic Pharmacists work with St. Elizabeth Cancer Care doctors to help develop a personalized approach to patient treatment plans, improving outcomes, and enhancing the overall quality of care. Learn more about Precision Medicine and Pharmacogenomics at: https://bit.ly/49PnlLY

White Paper: our white paper detailing the epigenetic keys to unlocking the full potential of immunotherapy is now available on our website. Click to download: tinyurl.com/4jsyt6bp #Epigenetics

Cardio-Oncology Developments: Just heard a great presentation by #JoséEnriqueOrtegaSollero regarding CD69 deficient mice and increased cardiac toxicity from anti-PD1 drugs. As the use of these amazing antiPD1 medications continues to expand across multiple cancer types, we have to understand the mechanisms and how we can translate the basic science like we heard today, into clinical practice. Shout out to oncologists, onco-PCPs, survivorship clinicians, cardiologists, ER providers and any other clinicians who may encounter anti-PD-1 complications in their daily clinical practice. Bottom line, why does this science matter?: People sometimes die of the treatment instead of the disease. Let's learn how to prevent that. Looking forward to future experiments from Dr. Sollero’s group.

Assessing key factors like cT stage, cN stage, and tumor length can help predict the response of advanced esophageal squamous cell carcinoma to neoadjuvant chemotherapy and immunotherapy. By incorporating these factors into a personalized nomogram, healthcare providers can better anticipate treatment outcomes and tailor strategies for individual patients, leading to more effective care and improved patient outcomes. #ESCC #NeoadjuvantTherapy #Immunotherapy #PersonalizedMedicine #CancerTreatment BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X. Read more about this post here: https://lnkd.in/e97hhts3

Learn about our science! Sialoglycans are crucial to our glycan editing approach – research suggests that when immune and tumor cells are heavily populated with sialoglycans, also known as hypersialylation, immune evasion can occur. Visit our website to learn more:  https://bit.ly/3DUGdvt #glycotime

At Rapid Novor they are using the power of #LCMS to transform patient care. Their groundbreaking diagnostic test, EasyM, is making a real difference in the lives of patients with multiple myeloma—a blood cancer that requires precise monitoring and treatment. With EasyM , Zac McDonald and his colleagues at Rapid Novor have swapped invasive biopsies with accesible serum based methods for sensitive disease monitoring. The use of LC-MS based proteomics in a clinical setting has tremendous potential to revolutionize patient care by providing accurate, reproducible, and sensitive diagnostic tools. As we continue to advance our understanding and application of mass spectrometry techniques, we open up new possibilities for personalized medicine and improved patient outcomes. #ClinicalProteomics #PatientCare #MedicalInnovation #EasyM

⚡Transforming Cancer Detection: The Power of a Simple Blood Test ⚡ Circulating cell-free DNA testing is a breakthrough in cancer screening, allowing for early detection through a simple blood draw. This non-invasive approach can identify cancers at their most treatable stages, offering hope for better outcomes and personalized treatment strategies. Early detection with PUER truly transforms lives! 🌞 #PUER #PUERInsight #CancerResearch #longevity #health #wellness #healthspan #lifespan #medicine #healthyaging #futureofhealth #cancer #DNA #PrecisionMedicine #CancerScreening  #HealthInnovation